Skip to main content

Advertisement

SpringerLink
Log in

Ala54Thr Polymorphism of Fatty Acid Binding Protein 2, Role on Insulin Resistance and Cardiovascular Risk Factors in Presurgical Morbid Obesity Patients

  • Clinical Report
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

A transition G to A at codon 54 of fatty acid binding protein 2 (FABP2) results in an amino acid substitution (ala 54 to Thr 54). This polymorphism was associated with insulin resistance in some populations.

Objective

The aim of our study was to investigate the influence of Thr54 polymorphism in the FABP2 gene on obesity anthropometric parameters, cardiovascular risk factors, and adipocytokines in patients with presurgical morbid obesity.

Design

A population of 55 morbid obese patients was enrolled. An indirect calorimetry, tetrapolar electrical bioimpedance, blood pressure, a serial assessment of nutritional intake with 3 days of written food records, and biochemical analysis (lipid profile, adipocytokines, insulin, C-reactive protein, and lipoprotein-a) were performed. The statistical analysis was performed for the combined Ala54/Thr54 and Thr54/Thr54 as a mutant-type group and wild-type group (Ala54/Ala54).

Results

Twenty nine (52.7%) had the genotype Ala54/Ala54 (wild-type group) and 26 (47.3%) patients had the genotype Ala54/Thr54 (24 patients, 43.7%) or Thr54/Thr54 (two patients, 3.6%; mutant-type group). Insulin (22.4 ± 16.8 vs. 26.1 ± 17.1 mg/dl; p = 0.04) and homeostasis model assessment (6.1 ± 2.1 vs. 6.7 ± 4.5; p = 0.04) levels were higher in mutant-type group than wild-type group. In mutant-type group, leptin levels (134.8 ± 83 vs. 206.5 ± 76 ng/ml; p = 0.03) were higher than wild-type group. Moreover, adiponectin levels (80.9 ± 39.6 vs. 23.9 ± 13.8 ng/ml; p = 0.02) were higher in wild-type group than mutant-type group.

Conclusion

The novel finding of this study is the association of Thr54 allele with insulin resistance, leptin, and adiponectin levels in morbidly obese patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rosenbaum M, Leibel RL, Hirsh J. Medical progress: obesity. New Engl J Med. 1997;337:396–407.

    Article  CAS  Google Scholar 

  2. Scopinaro N, Adami GF, Marinari GM. Biliopancreatic diversión. World J Surg. 1998;22:936–46.

    Article  CAS  Google Scholar 

  3. de Luis DA, Pacheco D, Aller R, et al. Influence of -55CT polymorphism of UCP3 gene on surgical results of biliopancreatic diversion. Obes Surg. 2008;. doi:10.1007/s11695-008-9510-2.

    Article  Google Scholar 

  4. de Luis DA, González Sagrado M, Izaola O, et al. Influence of Ala54Thr polymorphism of fatty acid-binding protein-2 on clinical results of biliopancreatic diversion. Nutrition. 2008;24:300–4.

    Article  Google Scholar 

  5. de Luis DA, Pacheco D, Aller R, et al. Influence of G308 polymorphism of Tumor necrosis alpha gene on surgical results of biliopancreatic diversion. Obes Surg 2008 (in press)

  6. Matsuda M, Shimomura I, Sata M. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem. 2002;277:37487–91.

    Article  CAS  Google Scholar 

  7. Kumada M, Kihara S, Sumitsuji S. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol. 2003;23:85–9.

    Article  CAS  Google Scholar 

  8. Shimomoura I, Hammer RE, Ikemoto S. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature. 1999;401:73–6.

    Article  Google Scholar 

  9. Steppan CM, Bailey ST, Bhat S. The hormone resistin links obesity to diabetes. Nature. 2001;409:307–12.

    Article  CAS  Google Scholar 

  10. Matsuzawa Y. Adipocytokines: emerging therapeutic targets. Curr Atheroscler Rep. 2005;7:58–62.

    Article  CAS  Google Scholar 

  11. Okasaki T, Himeno E, Nanri H, et al. Effects of mild aerobic exercise and a mild hypocaloric diet on plasma leptin in sedentary women. Clin Exp Pharmacol. 1999;26:415–20.

    Article  Google Scholar 

  12. Xenachis C, Samojlik E, Raghuwanshi MP, et al. Leptin, insulin and TNF-alpha in weight loss. J Endocrinol Invest. 2001;24:865–70.

    Article  CAS  Google Scholar 

  13. Besnard P. Cellular and molecular aspects of fat metabolism in the small intestine. Proc Nutr Soc. 1996;5:19–37.

    Article  Google Scholar 

  14. Baier LJ, Sacchettini JC, Knowler WC. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest. 1995;95:1281–7.

    Article  CAS  Google Scholar 

  15. Albala C, Santos JL, Viallaroel AC, et al. Intestinal FABP2 A54T polymorphism: association with insulin resistance and obesity in women. Obes Res. 2004;12:340–5.

    Article  CAS  Google Scholar 

  16. Duart MJ, Arroyo CO, Moreno JL. Validation of a insulin model for the reactions in RIA. Clin Chem Lab Med. 2002;40:1161–7.

    Article  Google Scholar 

  17. Mathews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–4.

    Article  Google Scholar 

  18. Pfutzner A, Langefeld M, Kunt T, et al. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin Lab. 2003;49:571–6.

    PubMed  Google Scholar 

  19. Meier U, Gressner M. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem. 2004;50:1511–25.

    Article  CAS  Google Scholar 

  20. Suominen P. Evaluation of an enzyme immunometric assay to measure serum adiponectin concentrations. Clin Chem. 2004;50:219–21.

    Article  CAS  Google Scholar 

  21. Lubrano V, Cocci F, Battaglia D, et al. Usefulness of high-sensitivity IL6 measurement for clinical characterization of patients with coronary artery disease. J Clin Lab Anal. 2005;19:110–4.

    Article  CAS  Google Scholar 

  22. Khan SS, Smith MS, Reda D, et al. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufactures. Cytometry B Clin Cytom. 2004;61:35–9.

    Article  Google Scholar 

  23. Pichard C, Slosman D, Hirschel B, et al. Bioimpedance analysis: an improved method for nutritional follow up. Clin Res. 1993;41:53.

    Google Scholar 

  24. Mataix J, Mañas M. Tablas de composición de alimentos españoles. Granada: University of Granada Ed; 2003.

    Google Scholar 

  25. Feurer ID, Mullen JL. Bedside measurement of resting energy expenditure and respiratory quotient via indirect calorimetry. Nutr Clin Pract. 1986;1:43–9.

    Article  Google Scholar 

  26. Sipilainen R, Uusitupa M, Heikkinen S, et al. Variants in the human intestinal fatty acid binding protein 2 gene in obese subjects. J Clin Endocrinol Metab. 1997;82:2629–32.

    Article  CAS  Google Scholar 

  27. Prochazka M, Lillioja S, Tait JF. Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians. Diabetes. 1993;42:514–9.

    Article  CAS  Google Scholar 

  28. Mitchell BD, Kammerer CM, O’Connell P. Evidence for linkage of postchallenge insulin levels with intestinal fatty acid-binding protein (FABP-2) in Mexican Americans. Diabetes. 1995;44:1046–53.

    Article  CAS  Google Scholar 

  29. Chiu KC, Chuang LM, Yoon C. The A54T polymorphism at the intestinal fatty acid binding protein 2 is associated with insulin resistance in glucose tolerant Caucasians. BMC Genet. 2001;2:7–13.

    Article  CAS  Google Scholar 

  30. Yamada K, Yuan X, Ishimayama S. Association between Ala 54Thr substitution of the fatty acid binding protein 2 gene with insulin resistance and intra abdominal fat thickness in Japanese men. Diabetologia. 1997;40:706–10.

    Article  CAS  Google Scholar 

  31. Kim CH, Yun SK, Byun DW. Codon 4 polymorphism of the fatty acid binding protein 2 gene is associated with increased fat oxidation and hyperinsulinemia but not with intestinal fatty acid absorption in Korean Men. Metabolism. 2001;50:473–6.

    Article  CAS  Google Scholar 

  32. de Luis DA, Sagrado MG, Aler R, et al. Influence of Ala54Thr polymorphism of fatty acid binding protein 2 on obesity and cardiovascular risk factors. Horm Metab Res. 2007;39:380–4.

    Google Scholar 

  33. Georgopoulos A, Aras O, Tsai MY. Codon 54 polymorphism of the fatty acid binding protein 2 gene is associated with elevation of fasting and postprandial triglyceride in type 2 diabetes. J Clin Endocr Metab. 2000;85:3155–60.

    CAS  PubMed  Google Scholar 

  34. Georgopoulos A, Aras O, Noutsou M, et al. Unlike type 2 diabetes, type 1 does not interact with the codon 54 polymorphism of the fatty acid binding protein 2 gene. J Clin Endocr. 2002;87:3735–9.

    Article  CAS  Google Scholar 

  35. Carlsson M, Orho Melander M, Hedenbro J, et al. The T54 allele of the intestinal fatty acid-binding protein 2 is associated with parenteral history of stroke. J Clin Endocr Metab. 2000;85:2801–4.

    CAS  PubMed  Google Scholar 

  36. Duarte NL, Colagiuri S, Palu T, et al. Obesity, type II diabetes and the Ala54 Thr polymorphism of fatty acid binding protein 2 in the Tongan population. Mol Genet Metab. 2003;79:183–9.

    Article  CAS  Google Scholar 

  37. de Luis DA, Aller R, Izaola O, et al. Modulation of the response to a lifestyle modification in obese patients by ala54thr polymorphism of the fatty acid-binding protein 2 gene. Ann Nutr Metab. 2006;50:354–60.

    Article  Google Scholar 

  38. de Luis DA, Aller R, Izaola O, et al. Influence of ALA54THR polymorphism of FABP-2 on weight loss and insulin levels secondary to two hypocaloric diets: a randomized clinical trial. Diab Res Clin Pract. 2008;82:113–8. doi:10.1016/j.diabres.2008.07.005.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Endocrinology and Nutrition, Medicine School and Unit of Investigation, Hospital Rio Hortega, University of Valladolid, RD056/00013 RETICEF, Valladolid, Spain

    D. A. de Luis, M. Gonzalez Sagrado, R. Aller, O. Izaola, R. Conde & Enrique Romero

  2. Institute of Endocrinology and Nutrition, Medicine School, Valladolid University, C/Los perales 16, Simancas, 47130, Valladolid, Spain

    D. A. de Luis

Authors
  1. D. A. de Luis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Gonzalez Sagrado
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Aller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. O. Izaola
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Conde
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Enrique Romero
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. A. de Luis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Luis, D.A., Sagrado, M.G., Aller, R. et al. Ala54Thr Polymorphism of Fatty Acid Binding Protein 2, Role on Insulin Resistance and Cardiovascular Risk Factors in Presurgical Morbid Obesity Patients. OBES SURG 19, 1691–1696 (2009). https://doi.org/10.1007/s11695-009-9859-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-009-9859-x

Keywords

Search

Navigation